CAR-T Cell Therapy at Mayo Clinic

CAR-T Cell Therapy is an advanced form of personalized cancer immunotherapy that modifies a patient's own T cells so they can recognize and attack specific cancer cells. It is primarily used for selected blood cancers, including certain leukemias and lymphomas, when clinically appropriate.

Price : Price on Request

Why Price on Request?

The cost of CAR-T cell therapy varies significantly depending on the cancer type, eligibility assessment, cell collection and manufacturing, conditioning treatment, hospitalization, monitoring and management of potential treatment-related complications. A personalized cost estimate is therefore required.

Complete Description

CAR-T Cell Therapy at Mayo Clinic

CAR-T Cell Therapy at Mayo Clinic – Rochester is an advanced cellular therapy that uses the patient's own immune cells to target certain types of cancer.

The treatment involves collecting T cells from the patient's blood, modifying them in a specialized laboratory so they can recognize a specific cancer target, and then returning the modified cells to the patient's body.

Once administered, the modified cells can identify and attack cancer cells carrying the targeted marker.

CAR-T therapy is a highly specialized treatment and is considered only for eligible patients with specific types of cancer.

What Is CAR-T Cell Therapy?

CAR-T cell therapy, or chimeric antigen receptor T-cell therapy, is a form of personalized cellular immunotherapy.

The treatment uses the patient's own T cells and genetically modifies them to produce a chimeric antigen receptor (CAR).

This receptor helps the modified T cells recognize specific proteins on cancer cells.

How CAR-T Cell Therapy Works

CAR-T treatment generally involves several important stages:

• Patient evaluation

• T-cell collection

• Cell processing and modification

• CAR-T cell manufacturing

• Preparation before infusion

• CAR-T cell infusion

• Close medical monitoring

• Long-term follow-up

Each stage is carefully coordinated by a specialized medical team.

Patient Evaluation

Before CAR-T therapy, specialists perform a detailed evaluation to determine whether the treatment is appropriate.

Assessment may include:

• Cancer diagnosis confirmation

• Disease stage

• Previous treatment history

• Laboratory testing

• Imaging

• Organ-function assessment

• Infection screening

• General health evaluation

• Assessment of treatment eligibility

The patient's overall condition and previous therapies are important factors in determining suitability.

T-Cell Collection

If the patient is considered an appropriate candidate, T cells are collected from the patient's blood using a procedure known as leukapheresis.

During leukapheresis, blood is passed through a specialized machine that separates selected blood cells and returns the remaining blood components to the patient.

The collected T cells are then prepared for further processing.

CAR-T Cell Manufacturing

The collected T cells are sent for specialized laboratory processing.

The cells are modified so they can express a chimeric antigen receptor designed to recognize a particular cancer-associated target.

The modified cells are expanded to produce the required number of CAR-T cells for treatment.

This manufacturing process is highly specialized and requires strict quality controls.

Conditioning Treatment

Before the CAR-T cells are infused, patients may receive lymphodepleting chemotherapy.

This preparatory treatment helps create an environment in the body that can support the activity and expansion of the CAR-T cells after infusion.

The specific conditioning regimen depends on the treatment protocol and patient's clinical situation.

CAR-T Cell Infusion

Once the CAR-T cells are ready and the patient has completed the required preparation, the modified cells are administered through an intravenous infusion.

The treatment team carefully monitors the patient during and after the infusion.

Monitoring After CAR-T Therapy

Close monitoring is an important part of CAR-T treatment.

Patients may require observation for potential complications and treatment-related reactions.

Monitoring may include:

• Vital signs

• Blood tests

• Neurological assessments

• Blood-cell counts

• Organ-function testing

• Infection monitoring

• Assessment of treatment response

The level and duration of monitoring depend on the patient's condition.

Cancers Treated With CAR-T Therapy

CAR-T therapy is primarily used for selected hematologic cancers.

Depending on the specific therapy and eligibility criteria, it may be considered for certain:

• B-cell acute lymphoblastic leukemia (B-ALL)

• Diffuse large B-cell lymphoma (DLBCL)

• Large B-cell lymphomas

• Follicular lymphoma

• Mantle cell lymphoma

• Multiple myeloma

• Other selected blood cancers

Eligibility depends on the specific CAR-T product, cancer type, previous treatments and individual patient factors.

CAR-T Therapy for Relapsed or Refractory Cancer

CAR-T therapy may be considered for selected patients whose cancer has:

• Returned after previous treatment

• Failed to respond adequately to treatment

• Become resistant to standard therapies

These cases are generally referred to as relapsed or refractory cancer.

Treatment eligibility depends on the specific disease and approved or clinically appropriate indications.

CAR-T Therapy and Personalized Medicine

CAR-T therapy is considered a form of personalized cancer treatment because the patient's own immune cells are used to create the therapeutic product.

The treatment is developed specifically from the patient's collected T cells.

Potential Benefits of CAR-T Therapy

For eligible patients, CAR-T therapy may:

• Target specific cancer cells

• Provide an option after certain previous treatments have failed

• Produce significant responses in selected blood cancers

• Offer a personalized cellular treatment approach

• Provide an additional treatment option for certain relapsed or refractory cancers

Treatment outcomes vary according to the cancer type, patient characteristics and previous treatment history.

Potential Risks and Side Effects

CAR-T therapy can cause significant side effects and requires specialized medical monitoring.

Potential complications may include:

• Cytokine release syndrome (CRS)

• Neurologic side effects

• Fever

• Low blood-cell counts

• Infections

• Fatigue

• Low blood pressure

• Other treatment-related complications

The medical team monitors patients closely and provides appropriate treatment when complications occur.

Cytokine Release Syndrome

Cytokine release syndrome (CRS) is an immune-related reaction that can occur after CAR-T cell infusion.

Symptoms may include:

• Fever

• Chills

• Low blood pressure

• Rapid heartbeat

• Breathing difficulties

• Other systemic symptoms

The severity can vary, and patients receiving CAR-T therapy are monitored carefully for signs of CRS.

Neurologic Side Effects

Some patients may develop neurological complications after CAR-T therapy.

Possible symptoms may include:

• Confusion

• Difficulty speaking

• Tremors

• Headache

• Changes in alertness

• Seizures in severe cases

Patients are closely monitored for neurological changes following treatment.

CAR-T Therapy Follow-Up

After treatment, patients require ongoing follow-up.

Follow-up may include:

• Blood tests

• Imaging

• Disease monitoring

• Assessment of treatment response

• Monitoring of blood-cell counts

• Infection monitoring

• Evaluation for delayed treatment effects

Long-term follow-up is an important part of CAR-T cell therapy.

Multidisciplinary CAR-T Care

CAR-T therapy requires coordination between multiple specialists and healthcare professionals.

The care team may include:

• Hematologists

• Medical oncologists

• Cellular therapy specialists

• Laboratory specialists

• Oncology nurses

• Pharmacists

• Intensive-care specialists when required

• Neurology specialists when needed

• Other healthcare professionals

This coordinated approach helps manage the complex stages of cellular therapy.

International Patients

International patients interested in CAR-T therapy may need to undergo a detailed medical-record review before traveling for treatment.

Important documents may include:

• Pathology reports

• Bone marrow biopsy results

• Imaging reports

• Blood test results

• Previous chemotherapy records

• Immunotherapy records

• Stem cell transplant records

• Molecular and genetic test results

• Current medication list

• Previous treatment response information

A detailed review helps specialists determine whether further evaluation for CAR-T therapy may be appropriate.

Cost & Price on Request

Price: Price on Request

CAR-T cell therapy is a complex and highly specialized treatment, so the total cost can vary substantially.

Potential cost components may include:

• Specialist consultation

• Eligibility evaluation

• Laboratory testing

• T-cell collection

• Cell processing and manufacturing

• Conditioning chemotherapy

• CAR-T cell infusion

• Hospitalization

• Medical monitoring

• Management of treatment-related complications

• Follow-up testing

• Additional specialist services

A personalized cost estimate should therefore be requested after specialist evaluation.

Frequently Asked Questions

1. What is CAR-T cell therapy?

CAR-T cell therapy is a personalized cancer treatment that modifies a patient's own T cells so they can recognize and attack specific cancer cells.

2. What cancers can CAR-T therapy treat?

CAR-T therapy is mainly used for selected blood cancers, including certain leukemias, lymphomas and multiple myeloma. Eligibility depends on the specific cancer and treatment criteria.

3. How are CAR-T cells obtained?

The patient's T cells are collected from the blood through leukapheresis and then processed and modified in a specialized laboratory.

4. Is CAR-T cell therapy suitable for every cancer patient?

No. CAR-T therapy is appropriate only for selected patients who meet specific medical and treatment criteria.

5. How much does CAR-T cell therapy cost?

Price is available on request. The cost depends on the patient's evaluation, cell collection and manufacturing, conditioning treatment, hospitalization, monitoring and other required medical services.

Product Details

Product Name: CAR-T Cell Therapy

Hospital: Mayo Clinic – Rochester

Brand: Mayo Clinic

Country: United States

Specialty: Oncology & Cancer Care

Service Type: CAR-T Cell Therapy

Dashboard Price: 0

Customer-Facing Price: Price on Request

International Patients: Available

Location: Rochester, Minnesota, USA